Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

HPV (human papillomavirus) levels could identify cervical cancer risk earlier

This article was originally published in Clinica

Executive Summary

Women at high risk of developing cervical cancer could be identified 10 years or more before the appearance of the disease by measuring the viral load of human papillomavirus type 16 (HPV 16), according to the findings of two multinational studies. Writing in the June 24 issue of The Lancet, researchers from Sweden, Denmark and the US suggest that measurement of viral load could usefully be added to routine gynaecology examinations such as Pap screening.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT076568

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel